, /PRNewswire/ -- , a privately held manufacturer of over-the-counter (OTC) branded and private label products today announced ColoTest , its new Fecal Immunochemical Test (FIT) for colon cancer screening, is now available at 3,700 Walmart locations across the U.S. The FDA-cleared identifies the presence of hidden blood in the stool in support of the early detection of colon cancer or gastrointestinal disorders such as colitis, diverticulitis, and polyps.
Launched in , it is now available in thousands of retail locations as well as online at . A store locator provides consumers access to the location nearest them at . The vast majority of colon cancer deaths are considered preventable when identified in early stages.
Despite this, colon cancer remains a leading cause of cancer-related death in the U.S., with rates rising among younger adults in particular.
According to a recent report by the , nearly double the number of adults under 55 are being diagnosed with colorectal cancer compared to a decade ago, and colorectal cancer is now the leading cause of cancer deaths in men under the age of 50 (second in women under 50). Colonoscopies are the gold standard of screening for colorectal cancer. However, only some people become eligible for the procedure before age 45.
Other barriers to colonoscopy may include fear of the procedure, lack of adequate insurance/insurance coverage for the test or other issues. ColoTest offers a highly accurate and discreet alternative that anyone ca.